Altering master genetic regulators SNF5/INI1 and LIN28A to model and treat atypical teratoid/rhabdoid tumors |
The Johns Hopkins University School of Medicine / Eric Raabe |
Young Investigator Grants |
2011 |
Maryland |
High-throughput CAR NKT Library Screen for Improving Neuroblastoma Immunotherapy |
Baylor College of Medicine / Xavier Rios, MD/PhD |
Young Investigator Grants |
2020 |
Texas |
Modeling osteosarcoma to identify novel therapeutic targets.
|
Stanford University / Julien Sage |
Young Investigator Grants |
2006 |
California |
Identification of FDA approved drugs with anti-tumor activity in rhabdomyosarcoma.
|
Massachusetts General Hospital / David Langenau |
Young Investigator Grants |
2009 |
Massachusetts |
Identifying Therapeutic Vulnerabilities in Pediatric AML through Investigation of the MECOM Transcriptional Network |
Boston Children’s Hospital / Richard Voit, MD/PhD |
Young Investigator Grants |
2023 |
Massachusetts |
Targeting the Metabolic Drivers of Chemo Resistance in Acute Myeloid Leukemia |
Harvard University / Nick van Gastel, PhD |
Young Investigator Grants |
2018 |
Massachusetts |
Regulation of Hematopoietic Stem Cell Engraftment by the Endothelial Cell Niche |
Boston Children’s Hospital / Bradley Blaser, MD, PhD |
Young Investigator Grants |
2015 |
Massachusetts |
Identification of Novel Treatment Targets by Exploring the Interaction of Rhabdomyosarcoma-Associated Oncogenes with Cellular Context in a Mouse Model of Rhabdomyosarcoma |
Dana-Farber Cancer Institute / Simone Hettmer |
Young Investigator Grants |
2010 |
Massachusetts |
Investigating the Role of Circadian Rhythm in the Progression of Acute Myeloid Leukemia |
Boston Children’s Hospital / Samantha Morris, PhD |
Young Investigator Grants |
2013 |
Massachusetts |
The Role of LIN28B-let-7-PBK Axis on the Growth and Metastasis of Group 3 Medulloblastoma |
Emory University / Shubin Shahab, MD/PhD |
Young Investigator Grants |
2021 |
Georgia |